Tandem Diabetes Care Inc (TNDM) - Total Liabilities
Based on the latest financial reports, Tandem Diabetes Care Inc (TNDM) has total liabilities worth $1.02 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tandem Diabetes Care Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how Tandem Diabetes Care Inc's total liabilities have evolved over time, based on quarterly financial data. See TNDM net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tandem Diabetes Care Inc Competitors by Total Liabilities
The table below lists competitors of Tandem Diabetes Care Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Universal Insurance Holdings Inc
NYSE:UVE
|
USA | $2.18 Billion |
|
China Union Holdings Ltd
SHE:000036
|
China | CN¥1.69 Billion |
|
Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund
NYSE:PTA
|
USA | $610.54 Million |
|
Beijing E Hualu Info Tech
SHE:300212
|
China | CN¥9.30 Billion |
|
Ningbo Changhong Polymer Scientific & Technical Inc
SHG:605008
|
China | CN¥4.30 Billion |
|
Bellring Brands LLC
NYSE:BRBR
|
USA | $1.52 Billion |
|
Elco Ltd
TA:ELCO
|
Israel | ILA22.39 Billion |
|
Corbion N.V.
F:CSU
|
Germany | €674.30 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Tandem Diabetes Care Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TNDM market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 7.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.89 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tandem Diabetes Care Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tandem Diabetes Care Inc (2011–2025)
The table below shows the annual total liabilities of Tandem Diabetes Care Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $725.94 Million | +3.03% |
| 2024-12-31 | $704.56 Million | +10.26% |
| 2023-12-31 | $639.03 Million | +4.27% |
| 2022-12-31 | $612.84 Million | +29.83% |
| 2021-12-31 | $472.02 Million | +34.82% |
| 2020-12-31 | $350.11 Million | +166.99% |
| 2019-12-31 | $131.13 Million | +74.80% |
| 2018-12-31 | $75.02 Million | -39.74% |
| 2017-12-31 | $124.49 Million | +5.22% |
| 2016-12-31 | $118.32 Million | +91.92% |
| 2015-12-31 | $61.65 Million | +18.81% |
| 2014-12-31 | $51.89 Million | +11.17% |
| 2013-12-31 | $46.68 Million | -68.00% |
| 2012-12-31 | $145.87 Million | +71.06% |
| 2011-12-31 | $85.27 Million | -- |
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and … Read more